Non–FDG-Avid Primary Papillary Thyroid Carcinoma May Not Differ from FDG-Avid Papillary Thyroid Carcinoma
- 1 November 2013
- journal article
- Published by SAGE Publications in Thyroid®
- Vol. 23 (11) , 1452-1460
Abstract
FDG (2-[(18)F]Fluoro-2-D-deoxyglucose-positron emission tomography (PET)/computed tomography (CT), which can detect a change in glucose metabolism in cancer cells, has been introduced as a diagnostic and prognostic tool in papillary thyroid carcinoma (PTC). However, differences in the clinicopathological and biological characteristics between primary PTCs with FDG uptake and those without FDG uptake are not well established. A total of 188 patients with PTC who had preoperative PET/CT scans were enrolled to compare the differences of clinicopathological parameters between FDG-avid (F-PTC; n = 150) and non-FDG-avid tumors (FN-PTC; n = 38). Immunohistochemical staining for glucose transporter (GLUT)-1 and hypoxia-inducible factor-1 alpha (HIF-1α) was performed. FN-PTCs were smaller; had a lower incidence of lymphatic invasion, vascular invasion, multifocality, and central lymph node metastasis; and had a lower maximum standardized uptake value than F-PTCs. After exclusion of high-risk patients for recurrence, FN-PTCs remained smaller (p < 0.001) and had less lymphatic invasion (p = 0.061). Among tumors larger than the spatial resolution of the PET/CT scan, macrocalcification was more frequent in FN-PTC than in F-PTC (p = 0.043). While FN-PTC and F-PTC showed no difference in GLUT-1 expression (50% vs. 75%, p = 0.363), FN-PTC showed lower HIF-1α immunoreactivity than F-PTC (25.0% vs. 75.0%, p = 0.032). Tumor size and macrocalcification are clinicopathological differences between FN-PTC and F-PTC. Biologically, HIF-1α may be responsible for increased FDG uptake in PTC.Keywords
This publication has 49 references indexed in Scilit:
- Pelvic lymph node F‐18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancerCancer, 2010
- 18F-FDG-Uptake of Hepatocellular Carcinoma on PET Predicts Microvascular Tumor Invasion in Liver Transplant PatientsAmerican Journal of Transplantation, 2009
- Imaging of tumor glucose utilization with positron emission tomographyCancer and Metastasis Reviews, 2008
- The standardized uptake value for F‐18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survivalCancer, 2007
- 18FDG uptake in oesophageal adenocarcinoma: linking biology and outcomeJournal of Cancer Research and Clinical Oncology, 2007
- Biological correlates of FDG uptake in non-small cell lung cancerLung Cancer, 2007
- Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancerJournal of Cellular Physiology, 2004
- Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission TomographyJournal of Clinical Oncology, 2002
- Correlation of Glut-1 glucose transporter expression with [18F]FDG uptake in non-small cell lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2000
- On the Origin of Cancer CellsScience, 1956